Gynecologic Cancer News and Features
Women with epithelial ovarian cancer, the most common type, can safely take hormone replacement therapy (HRT).
Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Use of oral contraceptives, even short-term, offers significant long-term protection against endometrial cancer and the protective effect seems to linger for decades after contraceptive is discontinued.
An online registry that matches women with research studies and clinical trials enrolled study participants more quickly.
Access to specialty care for gynecologic cancers is limited in a significant portion of the country.
Gynecologic Cancer Clinical Trials
- Harms of Cigarette Smoking and Health Benefits of Quitting (Fact Sheet)
- Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions
- Late-Stage Lung Cancer Often Overtreated
- Biomarker May Predict Prognosis for Targeted Therapy in Patients With HER2-Negative Breast Cancer
- "Supportive care" may hold less stigma than "palliative care"
- Newly Identified Gene Mutations May Expand Indications for Existing Targeted Cancer Treatments
- Clinical Trial Populations May Not Represent Patients Using Studied Medications
- They Asked You: Conversations at the Cancer Patient's Bedside
- Two-Drug Combination Shows Promise Against One Type of Pancreatic Cancer
- MS Pain Management in Patients With Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|